Received Sep 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
COVID-19 infection; COVID-19 infection; This is a spontaneous report received from a Consumer or other non HCP,. A 78-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 06Aug2025 as dose 1, single (Batch/Lot number: unknown) at the age of 78 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE NUMBER UNKNOWN, SINGLE), for Covid-19 immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 infection". Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Patient stated that she have a prescription for Paxlovid. Toward the end of the call stated that patient got the Pfizer vaccines all around and patient just got a booster on 06Aug2025 and patient ended up getting it but patient guess that would going around. COVID after Pfizer Vaccines. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.